316 related articles for article (PubMed ID: 26297319)
1. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.
Politis M; Lahiri N; Niccolini F; Su P; Wu K; Giannetti P; Scahill RI; Turkheimer FE; Tabrizi SJ; Piccini P
Neurobiol Dis; 2015 Nov; 83():115-21. PubMed ID: 26297319
[TBL] [Abstract][Full Text] [Related]
2. Imaging microglial activation in Huntington's disease.
Tai YF; Pavese N; Gerhard A; Tabrizi SJ; Barker RA; Brooks DJ; Piccini P
Brain Res Bull; 2007 Apr; 72(2-3):148-51. PubMed ID: 17352938
[TBL] [Abstract][Full Text] [Related]
3. Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin.
Connolly C; Magnusson-Lind A; Lu G; Wagner PK; Southwell AL; Hayden MR; Björkqvist M; Leavitt BR
Neuroscience; 2016 Jun; 325():74-88. PubMed ID: 27033979
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
[TBL] [Abstract][Full Text] [Related]
5. Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
Pavese N; Gerhard A; Tai YF; Ho AK; Turkheimer F; Barker RA; Brooks DJ; Piccini P
Neurology; 2006 Jun; 66(11):1638-43. PubMed ID: 16769933
[TBL] [Abstract][Full Text] [Related]
6. Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology.
Rocha NP; Charron O; Latham LB; Colpo GD; Zanotti-Fregonara P; Yu M; Freeman L; Furr Stimming E; Teixeira AL
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33795375
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation in presymptomatic Huntington's disease gene carriers.
Tai YF; Pavese N; Gerhard A; Tabrizi SJ; Barker RA; Brooks DJ; Piccini P
Brain; 2007 Jul; 130(Pt 7):1759-66. PubMed ID: 17400599
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic involvement in Huntington's disease: an in vivo PET study.
Politis M; Pavese N; Tai YF; Tabrizi SJ; Barker RA; Piccini P
Brain; 2008 Nov; 131(Pt 11):2860-9. PubMed ID: 18829696
[TBL] [Abstract][Full Text] [Related]
9. Early microglial activation and peripheral inflammation in dementia with Lewy bodies.
Surendranathan A; Su L; Mak E; Passamonti L; Hong YT; Arnold R; Vázquez Rodríguez P; Bevan-Jones WR; Brain SAE; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT
Brain; 2018 Dec; 141(12):3415-3427. PubMed ID: 30403785
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging in Huntington's Disease.
Wilson H; Politis M
Int Rev Neurobiol; 2018; 142():289-333. PubMed ID: 30409256
[TBL] [Abstract][Full Text] [Related]
11. Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
Wilson H; Niccolini F; Haider S; Marques TR; Pagano G; Coello C; Natesan S; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
J Neurol Sci; 2016 Sep; 368():243-8. PubMed ID: 27538642
[TBL] [Abstract][Full Text] [Related]
12. Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Niccolini F; Haider S; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Piccini P; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
Brain; 2015 Oct; 138(Pt 10):3016-29. PubMed ID: 26198591
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging in Huntington's Disease.
Roussakis AA; Piccini P
J Huntingtons Dis; 2015; 4(4):287-96. PubMed ID: 26683130
[TBL] [Abstract][Full Text] [Related]
14. Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease.
Du G; Dong W; Yang Q; Yu X; Ma J; Gu W; Huang Y
Front Immunol; 2020; 11():603594. PubMed ID: 33679692
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates.
Hannestad J; Gallezot JD; Schafbauer T; Lim K; Kloczynski T; Morris ED; Carson RE; Ding YS; Cosgrove KP
Neuroimage; 2012 Oct; 63(1):232-9. PubMed ID: 22776451
[TBL] [Abstract][Full Text] [Related]
16. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects.
Corey-Bloom J; Fischer RS; Kim A; Snell C; Parkin GM; Granger DA; Granger SW; Thomas EA
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887270
[TBL] [Abstract][Full Text] [Related]
17. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
Chang KH; Wu YR; Chen YC; Chen CM
Brain Behav Immun; 2015 Feb; 44():121-7. PubMed ID: 25266150
[TBL] [Abstract][Full Text] [Related]
18. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation in Huntington's Disease: New Insights with
Lois C; González I; Izquierdo-García D; Zürcher NR; Wilkens P; Loggia ML; Hooker JM; Rosas HD
ACS Chem Neurosci; 2018 Nov; 9(11):2563-2571. PubMed ID: 29719953
[TBL] [Abstract][Full Text] [Related]
20. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
Björkqvist M; Wild EJ; Thiele J; Silvestroni A; Andre R; Lahiri N; Raibon E; Lee RV; Benn CL; Soulet D; Magnusson A; Woodman B; Landles C; Pouladi MA; Hayden MR; Khalili-Shirazi A; Lowdell MW; Brundin P; Bates GP; Leavitt BR; Möller T; Tabrizi SJ
J Exp Med; 2008 Aug; 205(8):1869-77. PubMed ID: 18625748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
